Leerink Partners Remains Bullish as Conmed's (CNMD) Growth Acceleration Shows Evolving Turnaround

Go back to Leerink Partners Remains Bullish as Conmed's (CNMD) Growth Acceleration Shows Evolving Turnaround

Conmed (CNMD) Tops Q4 EPS by 1c; Guides

January 27, 2016 4:24 PM EST

Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.52, $0.01 better than the analyst estimate of $0.51. Revenue for the quarter came in at $191 million versus the consensus estimate of $191.03 million.

GUIDANCE:

Conmed sees FY2016 EPS of $1.85-$1.95, versus the consensus of $1.80. Conmed sees FY2016... More

Trading Radar for 1/27: Facebook (FB), General Dynamics (GD), eBay (EBAY), Qualcomm (QCOM), Sands (LVS) Report

January 26, 2016 3:09 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EST

MBA Mortgage Index - no Street consensus

Earnings:

02micro (Nasdaq: OIIM) - consensus loss $0.14
Anthem (Nasdaq: ANTM) - consensus EPS $1.22
Biogen (Nasdaq: BIIB) - consensus EPS $4.08
Boeing (NYSE: BA) - consensus EPS $1.26
Booz Allen Hamilton (NYSE: BAH) - consensus EPS... More